Profitability Ratios
| Ratio |
Value |
| GP Margin |
71.2% |
| EBIT Margin |
13.1% |
| EBITDA Margin |
21.3% |
| Operating Margin |
12.8% |
| Pretax Margin |
11.1% |
| Cont. Ops Margin |
9.4% |
| Net Margin |
8.2% |
| Bottom Line Margin |
8.2% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
0.78 |
| Quick Ratio |
0.52 |
| Solvency Ratio |
0.111 |
| Cash Ratio |
0.17 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
21.39 |
| PEG Ratio |
-0.44 |
| Forward PEG |
-0.44 |
| Price/Book |
4.03 |
| Price/Sales |
1.76 |
| Price/FCF |
15.42 |
| Price/Op Cash Flow |
8.41 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.2857 |
| Debt/Equity |
1.2425 |
| Debt/Capital |
0.5541 |
| Long-Term Debt/Capital |
0.5006 |
| Financial Leverage |
4.35 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
-8.06 |
| Operating Cash Flow Ratio |
0.302 |
| Operating Cash Flow/Sales |
20.9% |
| Free Cash Flow/Operating Cash Flow |
54.5% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
2.16 |
| Interest Coverage |
6.1148 |
| Short-Term Operating Cash Flow Coverage |
3.01 |
| Operating Cash Flow Coverage |
0.39 |
| Capital Expenditure Coverage |
2.20 |
| Dividend + Capital Expenditure Coverage |
1.21 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
94.9126% |
| Dividend Yield |
4.4363% |
| Dividend Yield % |
4.4363% |
| Dividend Per Share |
1.1989 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
15.39 |
| EPS |
1.263 |
| Debt/Share |
8.6552 |
| Cash/Share |
1.82 |
| Book Value/Share |
6.42 |
| Tangible BV/Share |
-4.62 |
| Equity/Share |
6.71 |
| Operating Cash Flow/Share |
3.215 |
| Capital Expenditure/Share |
1.463 |
| FCF/Share |
1.752 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.741 |
| Earnings Before Tax/EBIT |
0.865 |
| Price/Fair Value |
4.03 |
| Debt/Market Cap |
0.2883 |
| Effective Tax Rate |
15.1% |
| Enterprise Value Multiple |
10.26 |
GSK - GSK plc